Advertisement

Topics

Latest Neurology - Central Nervous System (CNS) NewsRSS

22:14 EDT 19th September 2017 | BioPortfolio

Global Circulating Tumor Cells Market Data Survey Report 2025 [Report Updated: 11082017] Prices from USD $1500

SummaryThis report mainly covers Circulating Tumor Cells products, by types CTC enrichment, CTC detection and CTC analysis, by applications Prostate Cancer, Breast Cancer, Colorectal Cancer Diagnosis and Treatment and Others.The global Circulating Tumor Cells market will reach Volume Million USD in 2017 with CAGR xx% 20182025. The main contents of the report including:Global market size and foreca...

#jobs #lifescience PhD Position – Epigenetic Characterization of Cancer Associated Fibroblasts

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: PhD Position – Epigenetic Characterization of Cancer Associated Fibroblasts .The group Stem Cell Biology and Cellular Engineering at the Helmholtz-Institute for Biomedical Engineering is offering a position for … Continue reading → Cet article #jobs #lifescie...

H. Lee Moffitt Cancer Center Research Institute Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24082017] Prices from USD $250

SummaryH Lee Moffitt Cancer Center Research Institute Inc Moffitt is a healthcare service provider that concentrates on the development of early stage translational research aimed at the rapid translation of scientific discoveries to benefit patient care. The center offers medical services such as surgical care, fertility preservation, radiation therapy, interventional radiology, rehabilitation s...

Cerveau Technologies, Inc. Announces Collaboration with Banner Health

Cerveau to provide support for MK-6240 use in clinical and basic research studies Cerveau Technologies Inc. today announced a research collaboration with Banner Health to support various research projects studying the stages of Alzheimer’s disease and other neurodegenerative diseases. These research projects will utilize an investigational imaging ag...

Pain Therapeutics Drugs, Markets and Companies [Report Updated: 08092017] Prices from USD $4000

SummaryThis report describes the latest concepts of pathomechanisms of pain as a basis for management and development of new pharmacotherapies for pain. Major segments of the pain market are arthritis, neuropathic pain and cancer pain. Because pain is a subjective sensation, it is difficult to evaluate objectively in clinical trials. Various tools for pain measurement are described, including brai...

RAC Gamma Serine/Threonine Protein Kinase Protein Kinase Akt 3 or Protein Kinase B Gamma or RAC PK Gamma or STK 2 or AKT3 or EC 2.7.11.1 Pipeline Review, H2 2017 [Report Updated: 29082017] Prices from USD $3500

RAC Gamma Serine/Threonine Protein Kinase Protein Kinase Akt 3 or Protein Kinase B Gamma or RAC PK Gamma or STK 2 or AKT3 or EC 2.7.11.1 Pipeline Review, H2 2017SummaryRAC Gamma Serine/Threonine Protein Kinase Protein Kinase Akt 3 or Protein Kinase B Gamma or RAC PK Gamma or STK 2 or AKT3 or EC 2.7.11.1 RACgamma serine/threonineprotein kinase is an enzyme encoded by the AKT3 gene. AKT3 regulate ...

Brides Against Breast Cancer® Donating 200 FREE Designer Wedding Dresses to Brides in Need – Seeking Applicants! Bringing Awareness of October Breast Cancer Month

While supplies last, a bride can select a dress on our web store, share her story why she needs it for free, and simply pay the shipping and handling! Brides Against Breast Cancer® (“BABC”) is giving away 200 designer wedding dresses (originally retailing up to $2,000) to brides in need. The bride picks the dress from our web store, shares her ...

Diverse Hispanic communities in New York City need information and services to help combat their higher risk for Alzheimer's disease

NEW YORK, Sept. 19, 2017 /PRNewswire-USNewswire/ -- In honor of Hispanic Heritage month September 15th – October 15th, the Alzheimer's Association- New York City Chapter is highlighting free resources and local programs available in both Spanish and English. Community outreach to the diverse Hispanic/ Latino communities is critically important because Hispanics are about one-and-one-half times m...

Southern Cancer Center is Global Leader in Kidney Cancer Clinical Trial

Southern Cancer Center (SCC), a premier oncology clinic in Alabama and a practice in The US Oncology Network, is the first site in the world to open enrollment for a new

Histone Deacetylase 2 (Transcriptional Regulator Homolog RPD3 or YY1 Associated Factor 1 or HDAC2 or EC 3.5.1.98) - Pipeline Review, H2 2017

LONDON, Sept. 19, 2017 /PRNewswire/ -- Histone Deacetylase 2 (Transcriptional Regulator Homolog RPD3 or YY1 Associated Factor 1 or HDAC2 or EC 3.5.1.98) - Pipeline Review, H2 2017Download the full report: https://www.reportbuyer.com/product/4423614SummaryHistone Deacetylase 2 (Transcriptional Regulator Homolog RPD3 or YY1 Associated Factor 1 or HDAC2 or EC 3.5.1.98) - Histone deacetylase 2 is an e...

NeuroPlus Brain-Sensing Headset, Developed to Improve Focus and Self Control in Adults and Children, Launches on Kickstarter with $100k Funding Goal

NeuroPlus uses an electroencephalography (EEG) headset with brain-controlled training games clinically proven to improve focus, calmness, and self-control Durham, NC (PRWEB) September 19, 2017 In a world teeming with distractions, the ability to focus and pay attention is crucial, whether at work, on the road or in the classroom. Recent research has shown that this ability, like any skill, can be...

Agilent Announces Expanded Use of Cancer Diagnostic in the United States

Dako PD-L1 IHC 28-8 PharmDx Approved for Two New Indications Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration (FDA) has approved the cancer diagnostic known as PD-L1 IHC 28-8 pharmDx for use in cases of urothelial carcinoma (UC) and of squamous cell carcinoma of the head and neck (SCCHN). The test ...

Cyclin Dependent Like Kinase 5 Serine/Threonine Protein Kinase PSSALRE or Tau Protein Kinase II Catalytic Subunit or Cell Division Protein Kinase 5 or CDK5 or EC 2.7.11.1 Pipeline Review, H2 2017 [Report Updated: 29082017] Prices from USD $3500

Cyclin Dependent Like Kinase 5 Serine/Threonine Protein Kinase PSSALRE or Tau Protein Kinase II Catalytic Subunit or Cell Division Protein Kinase 5 or CDK5 or EC 2.7.11.1 Pipeline Review, H2 2017SummaryAccording to the recently published report 'Cyclin Dependent Like Kinase 5 Pipeline Review, H2 2017'; Cyclin Dependent Like Kinase 5 Serine/Threonine Protein Kinase PSSALRE or Tau Protein Kinase I...

CorTechs Labs Receives 510(k) Clearance from US FDA for NeuroQuant for Quantitative Brain Image Analysis

Renewed FDA 510(k) clearance for NeuroQuant advances the field of quantitative imaging to support neurological professionals in their clinical decision making. San Diego, CA (PRWEB) September 19, 2017 CorTechs Labs, the leading medical software innovator providing solutions for quantitative brain volume analysis, is pleased to announce that it has received 510(k) clearance from the U.S. Food &...

Arkis BioSciences® Achieves FDA Clearance of its CerebroFlo™ EVD Catheter with Endexo® Technology

KNOXVILLE, Tenn., Sept. 19, 2017 /PRNewswire/ -- Arkis BioSciences, a leading innovator in minimally invasive surgical instrumentation, has obtained FDA clearance of its new external ventricular drainage catheter, CerebroFlo™.  According to Chad Seaver, CEO of Arkis BioSciences, the new catheter will be used for insertion into a ventricular cavity of the brain for external drainage of ...

Global Breast Cancer Imaging Market Usher Positive Growth Forecast at CAGR of 8.5% for the Forecasted Period 2016-2023: Occams Business Research & Consulting Pvt. Ltd.

INDORE, India, September 19, 2017 /PRNewswire/ -- Medical imaging involves different technologies used for monitoring, diagnosing and treatment of medical conditions, according to Food & Drug Administration (FDA). Since 2000, developments within medical technologies have transformed methods of disease diagnosis. Innovations in medical technologies such as magnetic resonance imaging, nuclea...

This October, share the message of early breast cancer detection

I love breast cancer awareness month. As a breast medical oncologist, it gives me an opportunity to spread the message of how important early detection is for improving the success of breast cancer treatment. I am surprised regularly at the number of women who either are not doing mammography at all or who do it […]

RNCG Angel Foundation Plans Costume Ball for “Scaring Off Cancer” Friday the 13th

Tampa, FL, September 19, 2017 --(PR.com)-- The RNCG Angel Foundation (www.rncgangelfoundation.org), a nonprofit 501(c)3 organization, is planning an enchanting evening “Under the Harvest Moon” as its theme for the annual “Scaring Off Cancer” fundraiser to support cancer patients and their families. Florida’s medical elite, business leaders, cancer survivors, and com...

Multiple Honors and Recognition for Genomind® as Record of Success Continues

KING OF PRUSSIA, Pa., Sept. 19, 2017 /PRNewswire/ -- Genomind, a personalized medicine company focused on improving mental healthcare through genetic testing, continues to collect a notable set of awards as it builds on its strategic plan. Inc. magazine named Genomind to its Inc. 5000 list of the fastest-growing private firms in America. It cited Genomind's impressive 157 percent growth...

Dr. David Samadi Launches Prostate Cancer Support Group at Lenox Hill Hospital

NEW YORK, Sept. 19, 2017 /PRNewswire/ -- Dr. David Samadi, world renowned prostate cancer surgeon, urologic oncologist and Chief of Robotic Surgery, is excited and pleased to announce the start of a prostate cancer support group beginning in September at Lenox Hill Hospital. The purpose is to assist individuals with information about prostate cancer and offer emotional support to men who are eithe...

AgeneBio Receives NIH Grant to Initiate Phase 3 HOPE4MCI Trial to Treat MCI Due to Alzheimer's Disease

BALTIMORE, Sept. 19, 2017 /PRNewswire/ -- AgeneBio, a pharmaceutical company developing innovative therapeutics for unserved patients battling neurodegeneration, today announced it has been awarded a grant from the National Institute on Aging (NIA) of the National Institutes of Health (NIH) to support its Phase 3 HOPE4MCI clinical trial for AGB101. AGB101 is the first and only therapeutic for...

Hyundai Hope On Wheels Awards $250,000 Research Grant to U-M C.S. Mott Children's Hospital in Honor of National Childhood Cancer Awareness Month

ANN ARBOR, Mich., Sept. 19, 2017 /PRNewswire/ -- Hyundai Hope On Wheels® will today present U-M C.S. Mott Children's Hospital with a $250,000 Hyundai Scholar Hope Grant. The grant funds will support the research of principal investigators Dr. Carl Koschmann and Dr. Gina Ney. This award is part of the organization's efforts during National Childhood Cancer Awareness Month.  In Septe...

VECT-HORUS Announces the Expansion of its Scientific Advisory Board

MARSEILLE, France, September 19, 2017 /PRNewswire/ -- VECT-HORUS is a French biotechnology company that designs and develops peptide-vectors to facilitate the delivery of drugs or imaging agents into the brain and other organs, and in particular in tumours. VECT-HORUS announces the expansion of its Scientific Advisory Board (SAB). Chaired by Prof. Jean-Michel SCHERRMANN, this Scientific Counci...

Scottish Scientists Claim that the Genome Controls the Aging of the Brain

Scientists in Scotland claim gene expression in the brain is so precisely controlled that they could predict your age just by looking at your genome.  Researchers at the University of Edinburgh believe that genes in the brain are expressed at ... This awesome article Scottish Scientists Claim that the Genome Controls the Aging of the Brain appeared first on Labiotech.eu. Be kind and don't copy it...

BERG Broadens Relationship With The Department Of Defense (DoD) Center For Prostate Disease Research With New Predictive Biomarker Test For Prostate Cancer

BOSTON, Sept. 19, 2017 /PRNewswire/ -- BERG, a biopharmaceutical company that merges biology with technology to map the nature of diseases, today announced the completion of clinical validation for a new predictive diagnostic test that can improve detection of prostate cancer. The new test can minimize unnecessary biopsies to distinguish men with prostate cancer compared to those with benign ...

Quick Search
Advertisement
 

review and buy Neurology - Central Nervous System (CNS) market research data and corporate reports here